期刊文献+
共找到860篇文章
< 1 2 43 >
每页显示 20 50 100
Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study 被引量:39
1
作者 Lin Lv Feng-Yun Wang +9 位作者 Xiang-Xue Ma Zhen-Hua Li Sui-Ping Huang Zhao-Hong Shi Hai-Jie Ji Li-Qun Bian Bei-Hua Zhang Ting Chen Xiao-Lan Yin Xu-Dong Tang 《World Journal of Gastroenterology》 SCIE CAS 2017年第30期5589-5601,共13页
AIM To assess the efficacy and safety of a Chinese herbal medicine (CHM), Xiangsha Liujunzi granules, in the treatment of patients with functional dyspepsia (FD). METHODS We performed a randomized, double-blind, place... AIM To assess the efficacy and safety of a Chinese herbal medicine (CHM), Xiangsha Liujunzi granules, in the treatment of patients with functional dyspepsia (FD). METHODS We performed a randomized, double-blind, placebo-controlled trial with patients from three centers. Two hundred and sixteen subjects diagnosed with FD according to ROME. criteria and confirmed by upper gastrointestinal endoscopy and spleen-deficiency and Qi-stagnation syndrome were selected to receive Xiangsha Liujunzi granules or placebo for 4 wk in a 2: 1 ratio by blocked randomization. The subjects also received follow-up after the 4-wk intervention. Herbal or placebo granules were dissolved in 300 mL of water. Participants in both groups were administered 130 mL (45 degrees C) three times a day. Participants were evaluated prior to and following 4 wk of the intervention in terms of changes in the postprandial discomfort severity scale (PDSS) score, clinical global impression (CGI) scale score, hospital anxiety and depression scale (HADS) score, traditional Chinese medicine symptoms score (SS), scores of various domains of the 36-item short form health survey (SF-36), gastric emptying (GE) and any observed adverse effects. RESULTS Compared with the placebo group, patients in the CHM group showed significant improvements in the scores of PDSS, HADS, SS, SF-36 and CGI scale (P < 0.05 or P < 0.01). They also showed the amelioration in the GE rates of the proximal stomach and distal stomach (P < 0.05 or P < 0.01). CONCLUSION Xiangsha Liujunzi granules offered significant symptomatic improvement in patients with FD. 展开更多
关键词 Functional dyspepsia Chinese herbal medicine Xiangsha liujunzi Efficacy Randomized controlled trial
暂未订购
Effects of Xiangsha Liujunzi decoction drug serum on gastric antrum smooth muscle cells from rats with functional dyspepsia by regulating gastrointestinal hormones 被引量:6
2
作者 Ning Dai Jinghong Hu +7 位作者 Yan Liu Dongyu Ge Ruijuan Dong Fengzhi Wu Jiaojiao Yu Mindan Chen Deborah CMa Feng Li 《Journal of Traditional Chinese Medical Sciences》 2020年第1期45-52,共8页
Objective:To observe the effect and mechanism of Xiangsha Liujunzi decoction(XSLJZD)drug serum on gastric antrum smooth muscle cells(SMCs)in rats with functional dyspepsia(FD).Methods:Gastric antrum SMCs from rats wit... Objective:To observe the effect and mechanism of Xiangsha Liujunzi decoction(XSLJZD)drug serum on gastric antrum smooth muscle cells(SMCs)in rats with functional dyspepsia(FD).Methods:Gastric antrum SMCs from rats with FD were isolated,cultured,and then divided into six groups as follows:control,model,domperidone,low-dose XSLJZD(LXSLJZD),medium-dose XSLJZD(MXSLJZD),and high-dose XSLJZD(HXSLJZD).Each group was administered the corresponding drug serum for intervention.Drug serum intervention conditions and proliferative activity of SMCs were tested by cholecystokinin octapeptide.Ghrelin,gastrin,somatostatin,and substance P(SP)levels were measured by ELISA.Somatostatin and SP mRNA expression was measured by real-time PCR.Results:A concentration of 10%drug serum for 24 h was decided to be the best intervention condition for later study.The mean optical density value in the model group was lower than that in the control group(P紏.001).Optical density values in the domperidone and HXSLJZD groups were higher than those in the model group(P?.025,P?.032,respectively).Gastrin,SP,and ghrelin levels in the model group were lower(P?.007,P?.037,P?.005,respectively),but somatostatin levels were higher,compared with those in the control group(P?.031).Gastrin,SP,and ghrelin levels in the domperidone,MXSLJZD,and HXSLJZD groups were higher than those in the model group(all P<.05).Somatostatin levels in the four drug-treated groups were lower than those in the model group(P?.002,P?.007,P?.001,P?.009,respectively).SP mRNA levels in the model group were lower than those in the control,domperidone,MXSLJZD,and HXSLJZD groups(P?.037 P?.016,P?.025,P?.002,respectively).Somatostatin mRNA levels in the model group were higher than those in the control and MXSLJZD groups(P紏.042,P紏.035).Conclusions:XSLJZD and domperidone drug serum effectively promote proliferative activity of gastric antrum SMCs in an FD model.The mechanism of this activity may be regulated by gastrointestinal hormones. 展开更多
关键词 Functional dyspepsia Xiangsha liujunzi decoction Gastrointestinal hormones Gastric antrum Smooth muscle cells
暂未订购
Mechanism underlying the effect of Liujunzi decoction(六君子汤)on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy 被引量:2
3
作者 XIN Xiaoli WANG Guodong +4 位作者 HAN Ru JIANG Yi LIU Chang LIU Lingshuang XU Zhenye 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2022年第1期108-115,共8页
OBJECTIVE:To further clarify the anticancer mechanisms of Liujunzi decoction(六君子汤)and provide possible targets for the treatment of advanced-stage nonsmall cell lung cancer(NSCLC)by re-analyzing differential gene ... OBJECTIVE:To further clarify the anticancer mechanisms of Liujunzi decoction(六君子汤)and provide possible targets for the treatment of advanced-stage nonsmall cell lung cancer(NSCLC)by re-analyzing differential gene expression profile of peripheral blood mononuclear cells(PBMCs)from Liujunzi decoctiontreated NSCLC patients receiving first-line chemotherapy.METHODS:The PBMC gene expression microarray data set GSE61926 was retrieved from a high throughput gene expression database.Differentially expressed genes(DEGs)were screened by paired sample t-test and the multiple ratio method.Gene ontology and Kyoto encyclopedia of genes and genomes(KEGG)pathway analyses were performed using the DAVID database.The protein–protein interaction(PPI)network was constructed using interaction gene library retrieval tools and Cytoscape software.RESULTS:A total of 162 DEGs were identified,with 67 upregulated genes and 95 downregulated genes.The functional distribution of Gene Oncology(GO)genes showed that DEGs were mostly concentrated in extracellular regions,calcium ion binding,and transcriptase activity.KEGG pathway analysis showed that cytokine–cytokine receptor interactions were significantly enriched.PPI network analysis screened out the top 10 central protein-coding genes with the highest nodal degree:IL2,PIWIL4,DICER1,PIWIL2,SAA1,XCL1,IL22RA1,ARHGAP11A,DCP1A,and GDNF.Among them,the central protein-coding gene with the highest node degree was IL2.In addition,the central protein-coding genes with high node degrees and high molecular complex detection(MCODE)scores were PIWIL4,DICER1,PIWIL2,and DCP1A,all of which are related to tumor development.CONCLUSIONS:One signaling pathway and 10 central protein-coding genes related to anticancer mechanisms were screened by re-analysis of GSE61926 data.IL2,PIWIL4,DICER1,PIWIL2,and DCP1 A may have important roles in the mechanism of Liujunzi decoction treatment against NSCLC.Our results suggest that the anticancer mechanism of Liujunzi decoction may be related to gene silencing by RNA and the biological processes of piwi-interacting RNA and other small RNAs. 展开更多
关键词 CARCINOMA non-small-cell lung antineoplastic agents computational biology RNA small interfering liujunzi decoction
原文传递
Liujunzi decoction ameliorats cisplatin-induced anorexia via adjusting metabolic disorders in rats
4
作者 DAI Yong-zhao CHEN Si-qi NIE Ke 《中国药理学与毒理学杂志》 CAS 北大核心 2021年第10期728-729,共2页
OBJECTIVE Cisplatin is a formidable chemotherapy agent widely applying in antineoplastic treatments,but its side effects often limit the clinical usage.Metabolic disorders are one of the side effects induced by cispla... OBJECTIVE Cisplatin is a formidable chemotherapy agent widely applying in antineoplastic treatments,but its side effects often limit the clinical usage.Metabolic disorders are one of the side effects induced by cisplatin,which closely relate to the onset of chemotherapy-induced anorexia(CIA)in cancer patients but lacks effective controls.Liujunzi decoction(LJZD)is a traditional Chinese formula that has a promising effect in treating CIA.However,whether LJZD ameliorates CIA through adjusting cisplatin-induced metabolic disorders remain unknow.The present study evaluated the mechanism of cisplatin-induced metabolic disorders,and the effect of LJZD in ameliorating these disturbances.METHODS 42 male Sprague-Dawley(SD)rats(180-220 g)were randomly divided into 3 groups:normal control group(distilled water+saline),model group(distilled water+cisplatin),LJZD group(4.8 g·kg^(-1)Liujunzi decoction ingredients+cisplatin).Intragastrical administered each drug twice a day(7∶00-19∶00)since day 0 for 4 d,animals were intraperitoneal injected with cisplatin 6 mg·kg^(-1)1 h after administration while normal control groups were injected with same volume of saline.On day 3,each group was anesthetized with pentobarbital sodium 45 mg·kg^(-1)(ip),and blood samples were collected from aorta abdominalis.Then the samples were analyzed using an LC-ESI-MS/MS system.Significantly regulated metabolites between groups were determined by VIP≥1 and absolute Log2FC(fold change)≥1.Identified metabolites were mapped to Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway database using Metaboanalyst 5.0(https://www.metaboanalyst.ca/).RESULTS A total of 133,77 and 32 differential metabolites were filtrated in control vs model,control vs LJZD and model vs LJZD groups respectively.Comparing to control,the levels of hexadecanoic acid(Log2FC=6.3153),linoleic acid(Log2FC=5.3478),and 8,11-icosadienoic acid(Log2FC=5.2342)significantly increased,and the levels of N-acetyl-L-tyrosine(Log2FC=-2.6283),cinnamic acid(Log2FC=-2.3381),N-acetylphenylalanine(Log2FC=-2.2501)significantly decreased in model group.The KEGG pathway enrichments of these metabolites indicated that,cisplatin-induced metabolic disorders by disturbing metabolism pathways such as linoleic acid metabolism,biosynthesis of unsaturated fatty acids,and phenylalanine metabolism,which suggested that the onset of CIA was partly associated with the metabolic disorders of linoleic acid,unsaturated fatty acids,and phenylalanine.Compared to control,treatment of LJZD significantly increased the levels of 4-hydroxytryptamine(Log2FC=12.0186),hexadecanoic acid(Log2FC=5.7412),linoleic acid(Log2FC=5.1877)and significantly decreased the levels of N-acetylmethionine(Log2FC=-1.7317),2-aminoethanesulfinic acid(Log2FC=-1.6578),N-acetyl-L-tyrosine(Log2FC=-1.5355).And comparing to the model group,4-hydroxytryptamine(Log2FC=12.0186),7,12-diketocholic acid(Log2FC=2.0998),N-acetylneuraminic acid(Log2FC=2.0560)markedly increased,and 3-hydroxy-3-methylpentane-1(Log2FC=-1.9202),5-dioic acid(Log2FC=-1.7166),N-isovaleroylglycine,hexanoyl glycine(Log2FC=-1.4958)markedly decreased in LJZD group.It was worth noting that,there were 23 differential metabolites filtrated both in control vs model and model vs LJZD groups,which were the key metabolites of LJZD in treating CIA.Among these 23 common metabolites,there were 16 metabolites excluding the control vs LJZD group,that was,LJZD had no effect in normal rats while being able to ameliorated cisplatin-induced metabolic disorders by regulating these 16 metabolites.Cisplatin-induced downregulation of 11 metabolites such as hydrocinnamic acid,(±)12(13)epoxy-9Z-octadecenoic acid,cinnamic acid were upregulated after LJZD treatment,and cisplatin-induced upregulation of imidazoleacetic acid,2′-deoxycytidine-5′-monophosphate and other 5 metabolites were downregulated by LJZD.The KEGG pathway analysis indicated that the linoleic acid metabolism,histidine metabolism,and pyrimidine metabolism were the most enriched metabolic pathway.Thus,cisplatin-induced metabolic disturbances mainly by disturbing linoleic acid metabolism,histidine metabolism,and pyrimidine metabolism,and LJZD interacted with these metabolic pathways to reduce metabolic disorders and thus ameliorated CIA.CONCLUSION Cisplatin-induced anorexia was closely related to the metabolic disorders of linoleic acid metabolism,biosynthesis of unsaturated fatty acids,and phenylalanine metabolism.The mechanism of LJZD in ameliorating CIA was in concerned with the metabolic adjustments,relating to the regulation of linoleic acid metabolism,histidine metabolism,and pyrimidine metabolism. 展开更多
关键词 liujunzi decoction chemotherapy-induced anorexia CISPLATIN METABOLOMIC metabolic disorders
暂未订购
Clinical Effect of Chemotherapy Combined with Chaishao Liujunzi Decoction in the Treatment of Breast Cancer
5
作者 ZHU Zumei 《外文科技期刊数据库(文摘版)医药卫生》 2021年第10期1086-1090,共8页
Objective: to study the therapeutic effect of chemotherapy combined with Chaishao Liujunzi decoction on breast cancer. Methods: 130 cases of breast cancer patients admitted to our hospital from September 2020 to Septe... Objective: to study the therapeutic effect of chemotherapy combined with Chaishao Liujunzi decoction on breast cancer. Methods: 130 cases of breast cancer patients admitted to our hospital from September 2020 to September 2021 were randomly divided into control group and experimental group according to the computer method. There were 65 cases in each group, and the patients in the control group received routine chemotherapy and medication. The patients in the experimental group were treated with Chaishao Liujunzi Decoction on the basis of the control group. The curative effect, TCM symptom score before and after the intervention and myelosuppression status (platelet count, white blood cell count and hemoglobin concentration) of the two groups were compared. Results: compared with the effective rate of comprehensive treatment, 64 cases (98.46%) in the experimental group and 58 cases (89.23%) in the control group were comprehensively effective (P < 0.05). Before treatment, there was no significant difference between the two groups (P>0.05). After treatment, the TCM waiting score of the experimental group was better than that of the control group (P<0.05). Before treatment, there was no significant difference in platelet count, leukocyte count and hemoglobin concentration between the two groups (P > 0.05). After treatment, the measurement results of various myelosuppression indexes in the experimental group were significantly better than those in the control group (P < 0.05). The incidence of adverse reactions in the experimental group on the 2nd day of chemotherapy was significantly lower than that in the control group (p < 0.05). Conclusion: the application of Chaishao Liujunzi Decoction in the clinical treatment of breast cancer patients undergoing chemotherapy can improve the patient's symptoms, and the curative effect is ideal. It is recommended to be popularized. 展开更多
关键词 CHEMOTHERAPY chaishao liujunzi decoction breast cancer clinical efficacy
暂未订购
Liujunzi Decoction Regulated Intestinal Flora Homeostasis to Relieve Lung–Gut Axis Inflammation in Asthma Flora Disorder Mice:Possibly Related to GATA3/ILC2
6
作者 XU Wen-ting WANG Qi +2 位作者 WU Xin-yu HUANG Jing-han WANG Jing 《Chinese Journal of Integrative Medicine》 2025年第11期1001-1010,共10页
Objective:To explore the effects and mechanism of Chinese medicine Liujunzi Decoction(LJZD)on regulating microbial flora in mice with asthma flora disorder.Methods:Thirty BALB/c female mice were divided into control,m... Objective:To explore the effects and mechanism of Chinese medicine Liujunzi Decoction(LJZD)on regulating microbial flora in mice with asthma flora disorder.Methods:Thirty BALB/c female mice were divided into control,model,LJZD[3.5 g/(kg·d),by gavage],dexamethasone[DXMS,0.7 mg/(kg·d),intraperitoneal injection],and Clostridium butyricum[CB,230 mg/(kg·d),by gavage]groups according to a random number table,6 mice in each group.The asthma flora disorder mice model was induced with ovalbumin(OVA).Lung and gut lesions were analyzed by hematoxylin-eosin(HE)and periodic acid-Schiff(PAS)stainings.The secretory immunoglobulin A(slgA)protein expression in lung and gut tissues was detected by Western blot.Flow cytometry was used to detect the relative counts of GATA binding protein 3(GATA3)/type 2 innate lymphoid cells(ILC2)in lung and gut.The levels of inflammatory factors in lung and gut tissues were detected by enzyme-linked immunosorbent assay(ELISA).Chao1 and Shannon index were used to compare microbial abundance and diversity in alveolar lavage fluid and cecal contents.The similarity or difference in the composition of mice microbial communities was analyzed through cluster analysis.The serum short-chain fatty acids(SCFAs)content was detected by ultra performance liquid chromatograph mass spectrometer(LC-MS)/MS.Results:The asthma flora disorder model mice showed obvious asthma-related symptoms,but LJZD treatment effectively alleviated these symptoms.LJZD restored alveolar wall thickening,airway inflammatory cell infiltration,gut tissue structure destruction,and inflammatory cell infiltration in asthma flora disorder mice.LJZD downregulated the slgA protein expression in mice(P<0.05).Moreover,LJZD decreased the activation of GATA3/ILC2s in lung and gut tissue(P<0.01),and reduced the levels of interleukin(IL)-5,IL-33,IL-25,IL-9 and IL-13(P<0.01).LJZD treatment returned the abundance of microbial species and the microbial community structure of alveolar lavage fluid and cecal content in asthma flora disorder mice to the normal state.The SCFAs content and body metabolism were also improved.Conclusion:LJZD exerted anti-asthmatic effects by improving the microbial balance of lung-gut axis and affecting systemic metabolism,consequently regulating the GATA3/ILC2s axis to impact the lung inflammatory response. 展开更多
关键词 liujunzi Decoction lung-gut axis microbial diversity GATA binding protein 3/type 2 innate lymphoid cells asthma flora disorder Chinese medicine
原文传递
加味香砂六君子汤调控高脂血症小鼠肠源性HDL3改善肝脏炎症反应的机制研究
7
作者 车梦竹 张琦 +3 位作者 隋国媛 闵冬雨 贾连群 杨关林 《中国中药杂志》 北大核心 2026年第1期232-240,共9页
探讨加味香砂六君子汤调控肠道高密度脂蛋白3(high-density lipoprotein 3,HDL3)水平改善高脂血症小鼠肝脏炎症的作用机制。将肠特异性ATP结合盒转运体A1(ATP-binding cassette transporter A1,ABCA1)基因敲除小鼠(Abcal-Villin-cre-Tg... 探讨加味香砂六君子汤调控肠道高密度脂蛋白3(high-density lipoprotein 3,HDL3)水平改善高脂血症小鼠肝脏炎症的作用机制。将肠特异性ATP结合盒转运体A1(ATP-binding cassette transporter A1,ABCA1)基因敲除小鼠(Abcal-Villin-cre-Tg)随机分为3组,每组8只:肠特异性敲除组(Abcal^(△Vill)组),肠特异性敲除高脂组(Abcal^(△Vill)+HFD组),肠特异性敲除中药干预组(Abcal^(△Vill)+HFD+M-XS组);同窝对照小鼠随机分为3组,每组8只:空白组(Abcal^(fl/fl)组),高脂组(Abcal^(fl/fl)+HFD组),中药干预组(Abcal^(fl/fl)+HFD+M-XS组)。除Abcal^(fl/fl)组和Abcal^(△Vill)组外,其余组给予高脂饲料饲养10周。连续给药6周,给药剂量23.66 g·kg^(-1)·d^(-1)。检测各组小鼠血脂四项;肝脏HE、油红O染色及回肠HE染色观察病理情况;酶联免疫吸附测定法(ELISA)检测小鼠回肠HDL3水平;GPO-PAP法检测肝脏甘油三酯(triacylglycerol, TG)水平;免疫荧光检测肝脏组织CD86与Toll样受体4(Toll-like receptor 4,TLR4)共定位情况;real-time PCR检测肝脏脂多糖结合蛋白(lipopolysaccharide-binding protein, LBP)、核转录因子-κB p65(nuclear factor kappa-light-chain-enhancer of activated B cells p65,NF-κB p65)、核因子-κBα抑制蛋白(inhibitor of nuclear factor kappa-B alpha, IκBα)、白细胞介素6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor alpha, TNF-α)、白细胞介素-1β(interleukin-1 beta, IL-1β)mRNA表达;Western blot检测回肠ABCA1、载脂蛋白A-I(apolipoprotein A-I,apoA-I)及肝脏LBP、p-NF-κB、p-IκBα、IL-6、TNF-α和IL-1β蛋白表达。结果显示,与Abcal^(fl/fl)组比,Abcal^(fl/fl)+HFD组血脂水平升高,肝脏出现大量空泡及脂滴,小肠绒毛变短,肝脏TG升高,回肠HDL3、ABCA1和apoA-I水平降低,肝脏CD86与TLR4呈现共定位,肝脏LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达升高,肝脏LBP、p-NF-κB、p-IκBα、IL-6、TNF-α及IL-1β蛋白表达显著升高(P<0.05);与Abcal^(fl/fl)+HFD组比,Abcal^(fl/fl)+HFD+M-XS组血脂水平降低,肝脏空泡及脂滴减少,小肠绒毛长度增加,肝脏TG降低,回肠HDL3、ABCA1和apoA-I水平升高,肝脏CD86与TLR4共定位程度减弱,LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达降低,LBP、p-NF-κB、p-IκBα、IL-6、TNF-α及IL-1β蛋白表达显著降低(P<0.05);与Abcal^(fl/fl)+HFD组比,Abcal^(△Vill)+HFD组血脂水平升高,肝脏空泡及脂滴增多,肝脏TG升高,肝脏CD86与TLR4共定位程度增强,LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达升高,LBP、p-NF-κB、p-IκBα、TNF-α及IL-1β蛋白表达显著升高(P<0.05);与Abcal^(fl/fl)+HFD+M-XS组比,Abcal^(△Vill)+HFD+M-XS组血脂水平升高,肝脏空泡及脂滴增多,肝脏TG升高,肝脏CD86与TLR4共定位增强,LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达升高,LBP、p-NF-κB、p-IκBα、IL-6、TNF-α及IL-1β蛋白表达显著升高(P<0.05)。结果表明,加味香砂六君子汤通过调节肠道HDL3水平,改善肝脏炎症反应,纠正血脂异常。 展开更多
关键词 加味香砂六君子汤 小鼠 回肠 高密度脂蛋白3 血脂
原文传递
基于UHPLC-Q/TOF-MS非靶向代谢组学分析六君子汤调节脾虚泄泻的作用机制
8
作者 钱景锐 廖志涵 +5 位作者 姜奇瑶 韩杉 喻良文 莫友胜 王奇 卓越 《中国药理学通报》 北大核心 2026年第1期172-180,共9页
目的从代谢水平解析经典名方六君子汤(Liujunzi decoction,LJZD)改善小鼠脾虚泄泻的潜在效应机制。方法将56只昆明小鼠分为空白组和模型组,采用番泻叶水煎液灌胃结合饮食失节法,建立脾虚泄泻小鼠模型。造模结束后将小鼠分为模型组、LJZ... 目的从代谢水平解析经典名方六君子汤(Liujunzi decoction,LJZD)改善小鼠脾虚泄泻的潜在效应机制。方法将56只昆明小鼠分为空白组和模型组,采用番泻叶水煎液灌胃结合饮食失节法,建立脾虚泄泻小鼠模型。造模结束后将小鼠分为模型组、LJZD低、中、高剂量组。LJZD低、中、高剂量组分别给予LJZD(10、20、30 g·kg^(-1)·d^(-1))灌胃,空白组及模型组给与等体积的生理盐水。记录体质量变化,比色法测定D-木糖含量、α-淀粉酶活性,WST-1法测定总超氧化物歧化酶,HE染色观察结肠黏膜组织形态,非靶向代谢组学筛选小鼠血清差异代谢物,结合网络药理学方法分析LJZD的潜在作用靶点和机制。结果与空白组相比,模型组体质量下降明显(P<0.01),D-木糖含量、α-淀粉酶活性、总超氧化物歧化酶活力明显下降(P<0.05,P<0.01),结肠黏膜组织损伤明显;与模型组相比,LJZD低、中剂量组体质量升高(P<0.05,P<0.01),D-木糖含量、α-淀粉酶活性、总超氧化物歧化酶活力明显升高(P<0.05,P<0.01),结肠上皮细胞和黏膜组织损伤明显改善。代谢组学PCA与OPLS-DA结果显示,LJZD组与模型组之间有差异,通过对照3组的交集,共找到13个LJZD治疗脾虚泄泻的生物标志物,联合分析共获得314个LJZD的潜在靶点,网络拓扑分析发现STAT3、MAPK1、EGFR、ESR1、MAPK3、JAK2、PIK3CA、IL-6等可能是LJZD的关键靶点,主要涉及PI3K/Akt信号通路、MAPK信号通路等。结论本研究揭示了LJZD可回调脾虚泄泻小鼠异常代谢轮廓发挥止泻作用,其效应机制可能与调控炎症及屏障修复等相关途径有关。 展开更多
关键词 六君子汤 脾虚泄泻 代谢组学 差异代谢物 PI3K/AKT信号通路 MAPK信号通路
暂未订购
六君子汤联合西医治疗对非小细胞肺癌术后慢性咳嗽患者中医证候及肺功能的影响
9
作者 刘家良 郑凯 《临床合理用药》 2026年第6期4-8,共5页
目的观察六君子汤联合西医治疗对非小细胞肺癌(NSCLC)术后慢性咳嗽患者中医证候及肺功能的影响。方法选择2022年3月—2025年3月辽宁中医药大学附属医院收治的NSCLC术后慢性咳嗽患者92例,按随机数字表法分为观察组和对照组,各46例。对照... 目的观察六君子汤联合西医治疗对非小细胞肺癌(NSCLC)术后慢性咳嗽患者中医证候及肺功能的影响。方法选择2022年3月—2025年3月辽宁中医药大学附属医院收治的NSCLC术后慢性咳嗽患者92例,按随机数字表法分为观察组和对照组,各46例。对照组予以西医常规治疗,观察组在对照组基础上联合六君子汤治疗,2组均持续治疗4周。比较2组临床疗效,治疗前后中医证候积分、肺功能[第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、FEV_(1)/FVC]、炎性因子[白介素-6(IL-6)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]及不良反应。结果观察组治疗总有效率(95.65%)高于对照组(82.61%)(χ^(2)=4.039,P=0.045)。治疗4周后,2组咳嗽反复发作、咳声低弱、痰多色白质稀积分低于治疗前,且观察组低于对照组(P<0.01);2组FEV_(1)、FVC、FEV_(1)/FVC高于治疗前,且观察组高于对照组(P<0.05或P<0.01);2组IL-6、CRP、TNF-α水平低于治疗前,且观察组低于对照组(P<0.01)。观察组与对照组不良反应总发生率比较差异无统计学意义(17.39%vs.13.04%,χ^(2)=0.337,P=0.562)。结论六君子汤联合西医治疗NSCLC术后慢性咳嗽患者疗效确切,可有效减轻其临床症状及炎性反应,促进肺功能改善,且不会明显增加不良反应。 展开更多
关键词 慢性咳嗽 非小细胞肺癌 术后 六君子汤 西医治疗 中医证候 肺功能 炎性因子 不良反应
原文传递
香砂六君子汤联合四联疗法治疗儿童幽门螺杆菌感染性消化性溃疡疗效分析
10
作者 王维 曹红 《中国烧伤创疡杂志》 2026年第1期60-64,共5页
目的分析儿童幽门螺杆菌感染性消化性溃疡应用香砂六君子汤联合四联疗法治疗的临床疗效。方法选取2021年6月至2024年6月南阳市第二人民医院收治的90例幽门螺杆菌感染性消化性溃疡患儿作为研究对象,依据随机数表法分为研究组(45例)与对照... 目的分析儿童幽门螺杆菌感染性消化性溃疡应用香砂六君子汤联合四联疗法治疗的临床疗效。方法选取2021年6月至2024年6月南阳市第二人民医院收治的90例幽门螺杆菌感染性消化性溃疡患儿作为研究对象,依据随机数表法分为研究组(45例)与对照组(45例),研究组患儿采用香砂六君子汤联合四联疗法治疗,对照组患儿单纯采用四联疗法治疗,对比观察两组患儿免疫指标、炎症介质与胃肠激素水平以及幽门螺杆菌根除率。结果治疗第7、14天,研究组患儿血管细胞黏附分子-1(VCAM-1)、肿瘤坏死因子-α(TNF-α)、环氧合酶-2(COX-2)以及胃泌素-17(GAS-17)、胃动素(MTL)水平均低于对照组(治疗第7天:t=2.360、2.497、2.372、2.165、8.176,P=0.021、P=0.014、P=0.020、P=0.033、P<0.001;治疗第14天:t=2.063、2.462、2.208、2.053、6.202,P=0.042、P=0.016、P=0.030、P=0.043、P<0.001),生长抑素(SST)水平均高于对照组(t=2.133、2.055,P=0.036、0.043);治疗结束后1个月,研究组患儿幽门螺杆菌根除率与对照组无明显差异(χ^(2)=3.462,P=0.063)。结论与单纯四联疗法治疗相比,香砂六君子汤联合四联疗法更能明显改善幽门螺杆菌感染性消化性溃疡患儿机体免疫功能,降低炎症反应程度,稳定胃肠功能状态,提高幽门螺杆菌清除效果。 展开更多
关键词 四联疗法 香砂六君子汤 儿童 消化性溃疡 幽门螺杆菌
暂未订购
加味六君子汤联合PD-1免疫抑制剂治疗肺癌患者的临床疗效
11
作者 崔红学 傅玲 +2 位作者 郑祎 董峰言 张明月 《中国医药指南》 2026年第3期144-146,共3页
目的对加味六君子汤联合PD-1免疫抑制剂在肺癌患者治疗中的临床疗效予以探讨。方法选取本院收治的90例非小细胞肺癌患者,均为2024年7月至2025年1月收治,以随机数字表法分为对照组与观察组,分别接受单纯PD-1免疫抑制剂治疗、PD-1免疫抑... 目的对加味六君子汤联合PD-1免疫抑制剂在肺癌患者治疗中的临床疗效予以探讨。方法选取本院收治的90例非小细胞肺癌患者,均为2024年7月至2025年1月收治,以随机数字表法分为对照组与观察组,分别接受单纯PD-1免疫抑制剂治疗、PD-1免疫抑制剂联合加味六君子汤治疗,每组45例。对比两组临床疗效。结果观察组临床治疗总有效率高于对照组,免疫功能优于对照组,中医证候积分低于对照组(P<0.05);两组不良反应发生率差异无统计学意义(P>0.05)。结论加味六君子汤联合PD-1免疫抑制剂应用于肺癌患者的治疗中,能够有效改善患者免疫功能、降低患者中医证候积分,且不会增加患者不良反应发生率,临床治疗效果好、安全性高,值得在临床中应用。 展开更多
关键词 肺癌 加味六君子汤 PD-1免疫抑制剂 中医证候积分
暂未订购
加味香砂六君子汤联合阿奇霉素肠溶片治疗糖尿病胃轻瘫脾胃虚弱证的临床疗效研究
12
作者 吴瑗 孙付霞 +2 位作者 刘蕊 赵云 吕娜 《中国合理用药探索》 2026年第1期136-142,共7页
目的:探讨加味香砂六君子汤联合阿奇霉素肠溶片治疗糖尿病胃轻瘫(DGP)脾胃虚弱证的临床疗效。方法:回顾性分析2022年6月~2025年6月期间于本院诊治的120例DGP脾胃虚弱证患者,按照治疗方法不同分为对照组(给予阿奇霉素肠溶片治疗,59例)和... 目的:探讨加味香砂六君子汤联合阿奇霉素肠溶片治疗糖尿病胃轻瘫(DGP)脾胃虚弱证的临床疗效。方法:回顾性分析2022年6月~2025年6月期间于本院诊治的120例DGP脾胃虚弱证患者,按照治疗方法不同分为对照组(给予阿奇霉素肠溶片治疗,59例)和治疗组(在对照组治疗基础上给予加味香砂六君子汤治疗,61例)。比较两组临床疗效、胃轻瘫核心症状指数(GCSI)评分、中医证候积分、胃动力指标、胃肠激素指标、氧化应激指标和不良反应发生情况。结果:治疗4周后,治疗组临床治疗总有效率(93.44%)高于对照组(81.36%,P<0.05);治疗组GCSI评分、中医证候积分、胃泌素(GAS)、血管活性肠肽(VIP)、胃动素(MTL)、丙二醛(MDA)、活性氧(ROS)均低于对照组,胃排空率、胃收缩频率、生长抑素(SS)、超氧化物歧化酶(SOD)均高于对照组,胃排空时间短于对照组(P<0.05)。治疗期间,两组不良反应总发生率比较无统计学差异(P>0.05)。结论:加味香砂六君子汤联合阿奇霉素肠溶片治疗DGP脾胃虚弱证,可提高临床疗效,缓解临床症状,改善胃动力,调节胃肠激素和减轻氧化应激反应。 展开更多
关键词 加味香砂六君子汤 糖尿病胃轻瘫 脾胃虚弱证 临床疗效 胃动力 胃肠激素 氧化应激
暂未订购
韩国伟教授运用晋阳儿科推拿联合香砂六君子汤治疗小儿功能性消化不良经验
13
作者 王瑞 韩国伟 +1 位作者 张建军 赵雨悦 《中医儿科杂志》 2026年第1期36-39,共4页
韩国伟教授指出小儿功能性消化不良的形成与脾胃有密切关系,临床多为饮食不节、喂养不当引起脾胃虚弱所致,治疗以醒脾健胃为主,兼以通腑消滞。韩教授以“调理脏腑、平衡阴阳”为基本的诊疗理念,采用晋阳儿科推拿,在诊断方法上强调四诊兼... 韩国伟教授指出小儿功能性消化不良的形成与脾胃有密切关系,临床多为饮食不节、喂养不当引起脾胃虚弱所致,治疗以醒脾健胃为主,兼以通腑消滞。韩教授以“调理脏腑、平衡阴阳”为基本的诊疗理念,采用晋阳儿科推拿,在诊断方法上强调四诊兼顾,取穴方式精简灵活,以手穴、体穴相互配伍,达到疏通经络、调节脏腑功能、平衡阴阳、调理脾胃的目的。中药配合香砂六君子汤以燥湿健脾、益气消滞、缓中止痛,临床疗效满意。附案例1则,以资验证。 展开更多
关键词 小儿功能性消化不良 晋阳儿科推拿 香砂六君子汤 临床经验 韩国伟
原文传递
香砂六君子汤加减内服联合理气止痛散热熨治疗胃癌脾虚痰湿证腹胀痛的临床观察
14
作者 赵慧 张曦尧 +1 位作者 钱美芬 王坚 《河北中医》 2026年第1期16-21,共6页
目的观察香砂六君子汤加减内服联合理气止痛散热熨治疗胃癌脾虚痰湿证腹胀痛患者的临床效果。方法选择2021年1月至2024年10月收治的105例胃癌脾虚痰湿证腹胀痛患者为研究对象,按照随机数字法分为治疗组和对照1组、对照2组,各35例。对照... 目的观察香砂六君子汤加减内服联合理气止痛散热熨治疗胃癌脾虚痰湿证腹胀痛患者的临床效果。方法选择2021年1月至2024年10月收治的105例胃癌脾虚痰湿证腹胀痛患者为研究对象,按照随机数字法分为治疗组和对照1组、对照2组,各35例。对照1组采用三阶梯规范治疗,对照2组基于对照1组方法加用香砂六君子汤加减内服治疗,治疗组在对照2组的基础上再联合理气止痛散热熨治疗。3组均治疗3周,比较3组中医证候疗效、临床客观疗效、临床疗效,比较3组治疗后疼痛程度、疼痛缓解起效时间、疼痛缓解持续时间、爆发痛发生次数、毒性反应分度情况,比较3组治疗前后KPS评分、抑郁自评量表(SDS)评分、血清癌胚抗原(CEA)水平情况。结果治疗组中医证候总有效率94.29%(33/35),临床客观疗效总缓解率85.71%(30/35),临床疗效总有效率94.29%(34/35),对照1组分别为65.71%(23/35)、57.14%(20/35)、65.71%(25/35),对照2组分别为82.96%(29/35)、71.43%(25/35)、82.96%(30/35),治疗组中医证总有效率、临床客观疗效总缓解率、临床疗效总有效率均高于对照1组、对照2组(P<0.05)。治疗组疼痛程度完全缓解率77.14%(27/35),对照1组完全缓解率28.57%(10/35),对照2组完全缓解率57.14%(20/35),治疗组疼痛程度完全缓解率均高于对照1组、对照2组(P<0.05)。治疗组治疗后疼痛缓解起效时间短于对照1组、对照组2组(P<0.05),疼痛缓解维持时间长于对照1组、对照2组(P<0.05),爆发痛发生次数均少于对照1组、对照2组(P<0.05)。与本组治疗前比较,3组治疗后KPS评分、SDS评分均升高(P<0.05),血清CEA水平均降低(P<0.05),且治疗组治疗后KPS评分、SDS评分均高于对照1组、对照2组(P<0.05),血清CEA水平均低于对照1组、对照2组(P<0.05)。治疗组治疗后毒性反应分度情况轻于对照1组、对照2组(P<0.05)。结论香砂六君子汤加减内服联合理气止痛散热熨治疗胃癌脾虚痰湿证腹胀痛患者疗效确切,可以在更短的时间内缓解疼痛且有较长的疼痛缓解时间,减少爆发痛发生次数,提高生活质量,改善患者情绪,降低CEA水平,减轻药物毒性反应。 展开更多
关键词 胃癌 脾虚痰湿型腹胀痛 香砂六君子汤 理气止痛散 热熨治疗
暂未订购
基于NF-κB信号通路探讨香砂六君子汤联合电针对术后早期炎性肠梗阻小鼠肠功能的影响 被引量:1
15
作者 李妮矫 张喆 +3 位作者 高春 许卫华 吕冉 赵锐恒 《辽宁中医杂志》 北大核心 2025年第8期193-196,I0005,共5页
目的基于NF-κB通路,探讨香砂六君子汤联合电针对术后早期炎性肠梗阻(early postoperative inflammatory small bowel obstruction,EPISBO)小鼠胃肠功能及Cajal间质细胞(interstitial cellsof Cajal,ICC)的影响。方法将40只小鼠随机分... 目的基于NF-κB通路,探讨香砂六君子汤联合电针对术后早期炎性肠梗阻(early postoperative inflammatory small bowel obstruction,EPISBO)小鼠胃肠功能及Cajal间质细胞(interstitial cellsof Cajal,ICC)的影响。方法将40只小鼠随机分为对照组、模型组、中药组(香砂六君子汤)、电针组和中药加电针组,每组8只。除了对照组以外,其余各组小鼠采用肠管表面擦拭法建立小鼠EPISBO模型。建造模型结束后隔一天进行处理,中药组用香砂六君子汤灌肠,电针组使用电针刺激;中药加电针组使用电针刺激,并灌胃服用香砂六君子汤治疗。每日1次,连续1周。取小鼠腹主动脉血清及小肠组织;HE染色检测小鼠小肠组织的结构和病理学变化,测量小肠推进率;ELISA检测小鼠血清白细胞介素-6(interleukin-6,IL-6)与肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)的浓度;Western blot检测小肠组织中c-kit(胃肠道Cajal间质细胞的特异性受体)和NF-κB通路中的关键蛋白p-p65和抑制蛋白IkB-α的蛋白表达。结果与对照组比,模型组小鼠的小肠推进率降低,小肠组织炎症程度加重,c-kit和IkB-α蛋白水平降低(P<0.001),IL-6和TNF-α水平及p-p65蛋白表达升高(P<0.001)。与模型组比较,中药组(香砂六君子汤)、电针组和中药加电针组的小肠推进率升高,小肠组织炎症程度减弱,c-kit和IkB-α蛋白水平升高(P<0.001),IL-6和TNF-α水平及p-p65蛋白表达降低(P<0.001)。中药加电针联合治疗的效果高于两者单独治疗的水平。结论香砂六君子汤联合电针可以减轻小鼠的炎症和肠梗阻的症状,并改善小鼠肠道功能,其机制可能与ICC的激活和NF-κB信号通路有关。 展开更多
关键词 术后炎性肠梗阻 香砂六君子汤 电针 NF-ΚB CAJAL间质细胞
原文传递
基于miR-1/HIF-1α轴研究六君子汤乙酸乙酯提取物调控食管癌细胞TE-1能量代谢的作用机制 被引量:1
16
作者 陈星 周哲旭 +6 位作者 尚艺婉 刘洋 刘娅茹 胡啸博 菅佳宁 肖小乔 陈玉龙 《中华中医药学刊》 北大核心 2025年第4期133-139,I0029,共8页
目的探索六君子汤乙酸乙酯提取物(EAELD)能否通过miR-1/HIF-1α轴调控食管癌细胞TE-1的能量代谢及其分子机制。方法前期实验已建立稳定转染阻滞miR-1表达细胞株(IN)及空白对照(NC),采用MTT法得到EAELD对NC的半数抑制浓度(IC_(50))及30%... 目的探索六君子汤乙酸乙酯提取物(EAELD)能否通过miR-1/HIF-1α轴调控食管癌细胞TE-1的能量代谢及其分子机制。方法前期实验已建立稳定转染阻滞miR-1表达细胞株(IN)及空白对照(NC),采用MTT法得到EAELD对NC的半数抑制浓度(IC_(50))及30%抑制浓度(IC_(30)),将其作为六高、六低浓度分别作用于IN与NC进行对比。实时荧光定量PCR(RT-qPCR)法检测EAELD对于TE-1细胞miR-1、HIF-1αmRNA的影响。双荧光素酶基因报告实验验证miR-1、HIF-1α靶向关系。然后将实验分组为NC组、六低组、六高组、IN+六低组、IN+六高组,Seahorse能量代谢分析系统检测线粒体压力与糖酵解速率,蛋白免疫印迹法(WB)检测能量代谢相关分子蛋白表达水平变化。结果MTT结果显示EAELD能够显著抑制NC增殖能力,呈浓度梯度依赖,选取20μg/mL(IC_(30))、40μg/mL(IC_(50))为低、高浓度组。RT-qPCR结果显示EAELD高浓度组显著促进miR-1的基因表达(P<0.05),HIF-1α有下降趋势,差异无统计学意义。双荧光素酶基因报告实验显示与野生型(WT)+阴性对照(mimics NC)组相比,WT+mimics荧光强度明显下降(P<0.05),与突变型(MUT)+阴性对照(mimics NC)组相比,MUT+mimics荧光强度无明显差别。将高、低浓度EAELD作用于IN时,MTT结果显示与NC相比,EAELD对于IN的抑制作用显著降低(P<0.05)。Seahorse能量代谢结果显示与NC组相比,EAELD高、低浓度组均可以抑制线粒体耗氧与糖酵解的比值(P<0.01,P<0.05)、糖酵解潜能(P<0.01)、基础呼吸值、质子漏耗氧(P<0.01,P<0.05)、线粒体最大耗氧能力、备用呼吸能力(P<0.01),高浓度组可以抑制基础糖酵解、补偿糖酵解、非线粒体耗氧、ATP合成耗氧(P<0.01)。与NC+六低组相比,IN+六低组的基础糖酵解、线粒体与基础糖酵解的比值、糖酵解潜能(P<0.05)、ATP合成耗氧(P<0.01)显著升高;与NC+六高组相比,IN+六高基础糖酵解、补偿糖酵解(P<0.05)、基础呼吸能力、质子漏耗氧、线粒体最大耗氧量、非线粒体耗氧显著升高(P<0.01)。WB结果显示与NC相比,EAELD高、低浓度组可以显著降低HK2(P<0.01)、GLUT1(P<0.05、P<0.01)、MCT1(P<0.01、P<0.05)蛋白相对表达量,高浓度组可以显著抑制PKM2(P<0.05)、MCT2、MCT4(P<0.01)的蛋白相对表达量;与NC+六低组相比,IN+六低组HK2、GLUT1、PKM2(P<0.01)、p-PKM2、MCT1、MCT2(P<0.05)的表达明显升高,与NC+六高组相比,IN+六高组可以显著促进HK2、GLUT1、PKM2、MCT4的表达(P<0.05)。结论六君子汤乙酸乙酯提取物可以通过下调能量代谢相关分子GLUT1、PKM2、p-PKM2、HK2、MCT1、MCT2、MCT4的蛋白表达抑制食管癌细胞TE-1的能量代谢,其部分机制与miR-1/HIF-1α轴有关。 展开更多
关键词 六君子汤乙酸乙酯提取物 食管癌 能量代谢 miR-1/HIF-1α轴 分子机制
原文传递
加味香砂六君子汤通过apoA-I-内质网应激途径改善高脂血症小鼠肝脏脂质沉积的作用机制
17
作者 张琦 隋国媛 +3 位作者 宋囡 蔡浩冉 崔运浩 贾连群 《中华中医药杂志》 北大核心 2025年第11期5186-5192,共7页
目的:探讨加味香砂六君子汤调控apoA-I-内质网应激途径影响甘油三酯(TG)合成进而改善高脂血症小鼠肝脏脂质沉积的机制。方法:apoA-I-/-及C57BL/6J小鼠各30只,随机分为KO组、KO+HFD组、KO+HFD+JWXS组及WT组、WT+HFD组、WT+HFD+JWXS组。... 目的:探讨加味香砂六君子汤调控apoA-I-内质网应激途径影响甘油三酯(TG)合成进而改善高脂血症小鼠肝脏脂质沉积的机制。方法:apoA-I-/-及C57BL/6J小鼠各30只,随机分为KO组、KO+HFD组、KO+HFD+JWXS组及WT组、WT+HFD组、WT+HFD+JWXS组。采用高脂血症模型并予加味香砂六君子汤干预。全自动生化分析仪检测血脂水平;HE及油红O染色观察肝脏病理情况;比色法检测肝组织NEFA水平;微板法检测肝组织TG水平;免疫荧光法检测肝组织GRP78荧光强度;RT-qPCR和Western Blot法检测肝组织ABCA1、apoA-I、PERK、p-PERK、SREBP-1c、ACC、FASN mRNA及蛋白表达。结果:给予加味香砂六君子汤干预后,WT+HFD+JWXS组血清中TG、HDL-C、LDL-C水平显著下调(P<0.05);肝组织中脂质沉积及GRP78荧光强度降低(P<0.05);apoA-ImRNA及蛋白表达显著升高(P<0.01,P<0.05)ACC、FASN mRNA及蛋白表达降低(P<0.05,P<0.01)。敲除apoA-I验证机制,WT+HFD组相较于WT组血脂水平升高(P<0.05,P<0.01);肝脏脂质沉积加重;肝组织中NEFA、TG水平升高,GRP78荧光强度增强,ABCA1 mRNA及蛋白表达降低,SREBP-1c、ACC、FASN mRNA及蛋白表达与p-PERK/PERK升高(P<0.05,P<0.01)。WT+HFD+JWXS组相较于WT+HFD组血清中TG、HDL-C、LDL-C水平降低(P<0.05,P<0.01);肝脏脂质沉积减轻;肝组织中NEFA、TG水平降低,GRP78荧光强度减弱,ABCA1 mRNA及蛋白表达升高,SREBP-1c、ACC、FASN mRNA及蛋白表达与p-PERK/PERK降低(P<0.05,P<0.01)。KO+HFD组较WT+HFD组血清中TC、TG、LDL-C水平升高(P<0.05,P<0.01),HDL-C水平降低(P<0.01);肝脏脂质沉积加重;肝组织中NEFA、TG水平升高,GRP78荧光强度增强,ABCA1 mRNA及蛋白表达降低,SREBP-1c、ACC、FASN mRNA及蛋白表达与p-PERK/PERK升高(P<0.05,P<0.01)。KO+HFD+JWXS组较WT+HFD+JWXS组血清中TG、LDL-C水平升高(P<0.05),HDL-C水平降低(P<0.01);肝脏脂质沉积加重;肝组织中NEFA、TG水平升高,GRP78荧光强度增强,ABCA1 mRNA及蛋白表达降低,SREBP-1c、ACC、FASN mRNA及蛋白表达与p-PERK/PERK升高(P<0.05,P<0.01)。结论:加味香砂六君子汤通过调控apoA-I-内质网应激途径影响TG合成,进而改善高脂血症小鼠肝脏脂质沉积。 展开更多
关键词 高脂血症 载脂蛋白A-I 内质网应激 加味香砂六君子汤 小鼠
原文传递
六君子汤合肾气丸化裁治疗脾肾气虚证慢性肾小球肾炎的临床效果观察 被引量:3
18
作者 张韧 苗悦 倪国忠 《临床误诊误治》 2025年第4期88-93,共6页
目的评价六君子汤合肾气丸化裁治疗脾肾气虚证慢性肾小球肾炎(CGN)的临床效果。方法选取2021年12月至2024年1月收治的脾肾气虚证CGN患者116例,根据随机数字表法分为对照组和观察组,每组58例。对照组根据患者临床表现予以控制血压、血脂... 目的评价六君子汤合肾气丸化裁治疗脾肾气虚证慢性肾小球肾炎(CGN)的临床效果。方法选取2021年12月至2024年1月收治的脾肾气虚证CGN患者116例,根据随机数字表法分为对照组和观察组,每组58例。对照组根据患者临床表现予以控制血压、血脂、蛋白尿等常规治疗,观察组在对照组基础上予以六君子汤合肾气丸化裁治疗,2组持续治疗8周。观察2组的临床疗效,以及治疗前后中医证候积分、肾功能指标[血尿素(BUN)、血肌酐(Scr)、24 h尿蛋白定量(24 h-Upro)]和炎性因子指标[血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)]水平。并记录2组治疗期间不良反应发生情况。结果观察组总有效率为94.83%(55/58),高于对照组的75.86%(44/58,P<0.05)。治疗后,2组各中医证候积分、BUN、Scr、24 h-Upro以及血清hs-CRP、IL-6、TNF-α水平均较治疗前降低,且观察组低于对照组(P<0.05)。2组治疗期间均无明显不良反应发生。结论六君子汤合肾气丸化裁治疗脾肾气虚证CGN患者具有良好的临床效果,能在一定程度上改善临床症状、肾功能和炎症反应,并具有一定的安全性。 展开更多
关键词 慢性肾小球肾炎 六君子汤 肾气丸 中医证候 血尿素 尿蛋白 肿瘤坏死因子-α 白细胞介素-6
暂未订购
基于ApoA-I/ATF3/TLR4/NF-κB信号轴探讨加味香砂六君子汤抑制高脂血症小鼠肝脏炎症反应的机制
19
作者 冷雪 张琦 刘慧慧 《中国中药杂志》 北大核心 2025年第19期5566-5573,共8页
探讨加味香砂六君子汤通过ApoA-I调节激活转录因子3(ATF3)影响肝脏炎症反应的作用机制。16只ApoA-I^(-/-)小鼠与24只C57BL/6J小鼠,适应性喂养1周后,将16只ApoA-I^(-/-)小鼠随机分为2组:高脂组、中药组;将24只C57BL/6J小鼠随机分为3组:... 探讨加味香砂六君子汤通过ApoA-I调节激活转录因子3(ATF3)影响肝脏炎症反应的作用机制。16只ApoA-I^(-/-)小鼠与24只C57BL/6J小鼠,适应性喂养1周后,将16只ApoA-I^(-/-)小鼠随机分为2组:高脂组、中药组;将24只C57BL/6J小鼠随机分为3组:空白对照组、高脂对照组、中药对照组。空白对照组普通饲料喂养,其余组高脂饲料喂养,8周后中药组及中药对照组给予加味香砂六君子汤灌胃。采用全自动生化分析仪检测小鼠血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平,苏木精-伊红(HE)及油红O染色观察小鼠肝组织病理形态学变化,酶联免疫吸附测定(ELISA)检测小鼠肝组织白细胞介素(IL)-1β、IL-6、肿瘤坏死因子-α(TNF-α)水平,实时荧光定量PCR(RT-qPCR)及蛋白免疫印迹法(Western blot)检测小鼠肝组织载脂蛋白A-I(ApoA-I)、ATF3、Toll样受体4(TLR4)、核因子-κB(NF-κB)mRNA及蛋白表达水平。结果显示,与空白对照组相比,高脂对照组小鼠血清TC、TG、HDL-C、LDL-C、ALT及AST水平显著升高(P<0.01);血清及肝组织IL-1β、IL-6、TNF-α含量及mRNA表达显著升高(P<0.01);肝组织ApoA-I、ATF3 mRNA及蛋白表达显著降低(P<0.01),TLR4、NF-κB mRNA及蛋白表达显著升高(P<0.01)。与高脂对照组相比,中药对照组小鼠血清TC、TG、HDL-C、LDL-C、ALT及AST水平显著降低(P<0.05,P<0.01);血清及肝组织IL-1β、IL-6、TNF-α含量及mRNA表达显著降低(P<0.05,P<0.01);肝组织ApoA-I、ATF3 mRNA及蛋白表达显著升高(P<0.05,P<0.01),TLR4、NF-κB mRNA及蛋白表达显著降低(P<0.05,P<0.01)。与高脂对照组相比,高脂组小鼠血清TC、TG、LDL-C、ALT及AST水平显著升高(P<0.01),HDL-C水平显著降低(P<0.01);血清及肝组织IL-1β、IL-6、TNF-α含量及mRNA表达显著升高(P<0.05,P<0.01);肝组织ATF3 mRNA及蛋白表达显著降低(P<0.05,P<0.01),TLR4、NF-κB mRNA及蛋白表达显著升高(P<0.05,P<0.01)。与中药对照组相比,中药组小鼠血清TC、TG、LDL-C、ALT及AST水平显著升高(P<0.05,P<0.01),HDL-C水平显著降低(P<0.01);血清及肝组织IL-1β、IL-6、TNF-α含量及mRNA表达显著升高(P<0.05,P<0.01);肝组织中ATF3 mRNA及蛋白表达显著降低(P<0.01),TLR4、NF-κB mRNA及蛋白表达显著升高(P<0.05,P<0.01)。结果表明,加味香砂六君子汤可能通过上调ApoA-I表达,激活ATF3进而抑制其下游TLR4/NF-κB通路,改善血脂异常所致炎症反应。 展开更多
关键词 加味香砂六君子汤 载脂蛋白A-I 炎症 转录因子3
原文传递
香砂六君子汤合小柴胡汤加减对急性胃炎患者炎症因子和胃肠激素水平的影响 被引量:3
20
作者 陈立梅 顾婷婷 +1 位作者 黄绪尧 曲效磊 《辽宁中医药大学学报》 2025年第7期206-210,共5页
目的探讨香砂六君子汤合小柴胡汤加减治疗急性胃炎(肝郁脾虚证)的临床疗效及对血清炎症因子、胃肠激素水平的影响。方法将116例急性胃炎(肝郁脾虚证)患者随机分为对照组(58例)和观察组(58例)。对照组给予兰索拉唑胶囊和铝碳酸镁咀嚼片... 目的探讨香砂六君子汤合小柴胡汤加减治疗急性胃炎(肝郁脾虚证)的临床疗效及对血清炎症因子、胃肠激素水平的影响。方法将116例急性胃炎(肝郁脾虚证)患者随机分为对照组(58例)和观察组(58例)。对照组给予兰索拉唑胶囊和铝碳酸镁咀嚼片等西医常规治疗,观察组在对照组基础上加服香砂六君子汤合小柴胡汤加减,疗程1周。比较治疗前后主要症状(胃脘痛、饱胀、恶心呕吐、嗳气、食欲减退)评分及肝郁脾虚证积分,记录主要症状消失时间或恢复正常时间,比较治疗前后世界卫生组织生存质量测定量表简表;检测治疗前后胃泌素(GAS)、胃动素(MOT)、神经肽Y(NPY)、5-羟色胺(5-HT)等胃肠激素水平;检测治疗前后血清炎症因子(IL-6、TNF-α、PCT和CRP)水平。结果观察组总有效率为87.93%,高于对照组的72.41%(P<0.05)。治疗后,两组患者主要症状评分及肝郁脾虚证积分下降(P<0.05),且观察组低于对照组(P<0.05)。治疗后观察组各主要症状消失时间均短于对照组(P<0.05)。治疗后,两组患者生活质量表4个维度评分及总分明显升高(P<0.05),且观察组高于对照组(P<0.05)。治疗后,两组患者MOT、NPY升高(P<0.05),GAS、5-HT和炎症因子(IL-6、TNF-α、PCT和CRP)降低(P<0.05),且均以观察组为显著(P<0.05)。结论香砂六君子汤合小柴胡汤加减内服治疗急性胃炎(肝郁脾虚证)患者,可调节胃肠激素、改善胃肠道动力,能抑制炎症反应、减轻胃肠炎性损伤,维护正常的胃肠功能,从而能减轻临床症状,促进主要症状的消失,缩短病程,提高临床疗效和生活质量。 展开更多
关键词 急性胃炎 肝郁脾虚证 香砂六君子汤 小柴胡汤 胃肠激素 炎症因子
原文传递
上一页 1 2 43 下一页 到第
使用帮助 返回顶部